[1]
BIBI , N. and MALIK , M. 2025. COMPARISON OF 550MG/DAY VERSES 1100 MG/DAY RIFAXIMIN IN SECONDARY PREVENTION OF BOTH COVERT AND OVERT HEPATIC ENCEPHALOPATHY. Pakistan Journal of Intensive Care Medicine. 5, 01 (May 2025), 71. DOI:https://doi.org/10.54112/pjicm.v5i01.71.